Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • NPPA revises price for...

    NPPA revises price for Ringer lactate -RL injection with special packaging

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2020-03-07T15:13:06+05:30  |  Updated On 7 March 2020 9:44 AM GMT
    NPPA revises price for Ringer lactate -RL injection with special packaging

    New Delhi: The apex drug price regulator, National Pharmaceutical Pricing Authority (NPPA) has decided to give a 15 percent increment to the pricing of Ringer lactate injection (RL) with special packaging that have reduced chances of contamination of the product

    Lactated Ringer's solution, or LR, is one of the two most common intravenous (IV) fluids used in the patient care at hospitals

    The decision to this effect was recently approved in its 205th (overall) and 73rd meeting of the Authority under DPCO, 2013 after it considered that after its committee noted minor innovation in the packaging of the ringer lactate injections.

    It is reported a group of manufacturers including M/s Albert David Ltd, M/s Aculife Healthcare Pvt. Ltd, M/s B. Braun Medical (India) Pvt. Ltd, M/s Fresenius Kabi India Pvt. Ltd M/s Ostuka Pharmaceuticals India Pvt. Ltd had filed a review application against ceiling price fixation of Ringer lactate Injection fixed vide S.O. 2401(E) dated 28.07.2017

    The Authority deliberated upon the 5 review orders dated 21.03.2018 in respect of 5 companies related to ringer lactate injection. The Authority was informed that as per decisions taken in its 69th meeting dated 08.08.2019, the matter had been referred to Department of Pharmaceuticals (DOP) vide communication dated 19.08.2019 wherein DOP was informed that a price increase due to special packaging may distort market prices and accordingly sought clear directions in this regard.

    DOP in its communication dated 16.12.2019 had replied to the above reference and requested to strictly implement review orders dated 21.03.2018.

    Hence, the matter was then referred to the Multidisciplinary Committee of Experts in which 2 pharmacoeconomics experts were also associated with 02.12.2019.

    The Authority was informed that the matter had been placed again in the 16th meeting of the Multidisciplinary Committee of Experts held on 13.02.2020 which noted that there is minor innovation in the packaging of the ringer lactate injection having special features like (i) self collapsibility and self-sealability (ii) not having air-vent and (iii) there is no chance of contamination during manufacture/ infusion/ admixing levels and recommended an increase of 15% in ceiling price over and above the present applicable ceiling price.

    The recommendation of the Committee was placed before the Authority and the Authority accepted the recommendation of the Committee and approved the ceiling price of ringer lactate injection with packages having special features as detailed below:

    S.

    No.

    Formulations

    Unit

    Ceiling Price

    excluding GST

    1

    Ringer lactate injection

    100 ml pack (having special features)

    Rs. 23.51

    2

    Ringer lactate injection

    250 ml pack (having special features)

    Rs. 40.08

    3

    Ringer lactate injection

    500 ml pack (having special features)

    Rs. 51.07

    4

    Ringer lactate injection

    1000 ml pack (having special features)

    Rs. 89.77

    ringer lactate injection national-pharmaceutical-pricing-authority 

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier

      This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:

      Search only trustworthy HONcode health websites:

      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

      © 2020 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      X